Video Experimental Relacionado

Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.5K

PepQueryMHC: priorización rápida y completa de antígenos tumorales a partir de datos de inmunopeptidómica

Seunghyuk Choi1,2,3, Bing Zhang4,5

  • 1Lester and Sue Smith Breast Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA.

Genome biology
|December 24, 2025
PubMed
Resumen

La identificación de péptidos tumorales específicos es clave para la inmunoterapia contra el cáncer. PepQueryMHC es una herramienta nueva y rápida que ayuda a priorizar antígenos tumorales a partir de datos de RNA-seq, mejorando el desarrollo de la inmunoterapia.

Palabras clave:
InmunoinformáticaInmunopeptidomaComplejo mayor de histocompatibilidadProteogenómicaAntígenos tumorales

Más Videos Relacionados

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.0K
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

14.8K

Videos de Conceptos Relacionados

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.